Barclays’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$233K Sell
9,009
-6,776
-43% -$175K ﹤0.01% 3445
2025
Q1
$160K Sell
15,785
-5,936
-27% -$60.2K ﹤0.01% 3450
2024
Q4
$303K Sell
21,721
-2,165
-9% -$30.2K ﹤0.01% 3325
2024
Q3
$466K Buy
23,886
+11,706
+96% +$228K ﹤0.01% 3034
2024
Q2
$227K Sell
12,180
-26,018
-68% -$485K ﹤0.01% 2982
2024
Q1
$535K Buy
38,198
+338
+0.9% +$4.73K ﹤0.01% 2792
2023
Q4
$321K Buy
37,860
+22,537
+147% +$191K ﹤0.01% 3269
2023
Q3
$137K Buy
15,323
+11,501
+301% +$103K ﹤0.01% 3198
2023
Q2
$33K Sell
3,822
-6,362
-62% -$54.9K ﹤0.01% 3845
2023
Q1
$108K Sell
10,184
-743
-7% -$7.88K ﹤0.01% 3486
2022
Q4
$372K Buy
10,927
+1,297
+13% +$44.2K ﹤0.01% 2762
2022
Q3
$463K Sell
9,630
-7,406
-43% -$356K ﹤0.01% 2630
2022
Q2
$971K Buy
17,036
+4,238
+33% +$242K ﹤0.01% 2100
2022
Q1
$1.04M Buy
12,798
+7,574
+145% +$613K ﹤0.01% 2279
2021
Q4
$1.06M Sell
5,224
-4,097
-44% -$831K ﹤0.01% 2168
2021
Q3
$2.51M Sell
9,321
-4,637
-33% -$1.25M ﹤0.01% 1703
2021
Q2
$3.59M Buy
13,958
+12,790
+1,095% +$3.29M ﹤0.01% 1381
2021
Q1
$350K Sell
1,168
-1,249
-52% -$374K ﹤0.01% 2862
2020
Q4
$616K Sell
2,417
-11,357
-82% -$2.89M ﹤0.01% 2235
2020
Q3
$3.43M Sell
13,774
-2,793
-17% -$695K ﹤0.01% 1168
2020
Q2
$5.76M Sell
16,567
-6,731
-29% -$2.34M ﹤0.01% 862
2020
Q1
$6.24M Buy
23,298
+12,461
+115% +$3.34M ﹤0.01% 778
2019
Q4
$3.51M Sell
10,837
-22,229
-67% -$7.2M ﹤0.01% 1491
2019
Q3
$9.03M Buy
33,066
+16,365
+98% +$4.47M 0.01% 820
2019
Q2
$8.91M Buy
16,701
+1,976
+13% +$1.05M 0.01% 867
2019
Q1
$7.42M Buy
14,725
+281
+2% +$142K 0.01% 849
2018
Q4
$7.12M Sell
14,444
-4,846
-25% -$2.39M 0.01% 829
2018
Q3
$17.6M Sell
19,290
-7,610
-28% -$6.96M 0.01% 582
2018
Q2
$19.7M Buy
26,900
+7,978
+42% +$5.84M 0.02% 501
2018
Q1
$30.2M Sell
18,922
-7,065
-27% -$11.3M 0.02% 434
2017
Q4
$23.3M Buy
25,987
+10,525
+68% +$9.43M 0.02% 441
2017
Q3
$5.57M Buy
15,462
+3,167
+26% +$1.14M 0.01% 769
2017
Q2
$3.61M Sell
12,295
-9,192
-43% -$2.7M ﹤0.01% 928
2017
Q1
$7.56M Buy
21,487
+15,004
+231% +$5.28M 0.01% 631
2016
Q4
$1.19M Buy
6,483
+6,158
+1,895% +$1.13M ﹤0.01% 1399
2016
Q3
$83K Sell
325
-430
-57% -$110K ﹤0.01% 2510
2016
Q2
$160K Buy
755
+521
+223% +$110K ﹤0.01% 2193
2016
Q1
$45K Sell
234
-2,347
-91% -$451K ﹤0.01% 2570
2015
Q4
$620K Sell
2,581
-226
-8% -$54.3K ﹤0.01% 1582
2015
Q3
$421K Buy
2,807
+348
+14% +$52.2K ﹤0.01% 1800
2015
Q2
$443K Sell
2,459
-2,114
-46% -$381K ﹤0.01% 1813
2015
Q1
$754K Sell
4,573
-1,923
-30% -$317K ﹤0.01% 1726
2014
Q4
$1.46M Buy
6,496
+4,744
+271% +$1.07M ﹤0.01% 1446
2014
Q3
$316K Sell
1,752
-27,440
-94% -$4.95M ﹤0.01% 2133
2014
Q2
$5.26M Buy
29,192
+18,793
+181% +$3.38M 0.01% 928
2014
Q1
$1.87M Buy
10,399
+8,818
+558% +$1.59M ﹤0.01% 1359
2013
Q4
$260K Sell
1,581
-32,384
-95% -$5.33M ﹤0.01% 2486
2013
Q3
$5.09M Buy
33,965
+18,072
+114% +$2.71M 0.01% 878
2013
Q2
$2.75M Buy
+15,893
New +$2.75M ﹤0.01% 1130